Waters Parkerson & Co’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$611K Buy
1,160
+150
+15% +$84.1K 0.03% 130
2026
Q1
$568K Hold
1,010
0.03% 127
2025
Q4
$683K Hold
1,010
0.03% 121
2025
Q3
$645K Hold
1,010
0.03% 121
2025
Q2
$542K Buy
1,010
+160
+19% +$76.5K 0.03% 128
2025
Q1
$357K Hold
850
0.02% 150
2024
Q4
$351K Sell
850
-463
-35% -$203K 0.02% 151
2024
Q3
$663K Buy
1,313
+395
+43% +$192K 0.03% 117
2024
Q2
$447K Buy
918
+68
+8% +$34.1K 0.02% 130
2024
Q1
$459K Hold
850
0.02% 129
2023
Q4
$472K Hold
850
0.03% 122
2023
Q3
$372K Hold
850
0.02% 129
2023
Q2
$427K Hold
850
0.02% 128
2023
Q1
$425K Hold
850
0.03% 125
2022
Q4
$347K Buy
850
+100
+13% +$38.8K 0.02% 135
2022
Q3
$244K Hold
750
0.02% 151
2022
Q2
$263K Hold
750
0.02% 148
2022
Q1
$410K Sell
750
-2
-0.3% -$1.05K 0.02% 133
2021
Q4
$495K Buy
752
+2
+0.3% +$1.26K 0.03% 127
2021
Q3
$466K Hold
750
0.03% 128
2021
Q2
$474K Hold
750
0.03% 125
2021
Q1
$367K Hold
750
0.02% 141
2020
Q4
$375K Hold
750
0.03% 134
2020
Q3
$295K Hold
750
0.02% 138
2020
Q2
$248K Buy
+750
New +$217K 0.02% 142

Other funds holding IDXX

Waters Parkerson & Co's IDXX Position: Q2 2026 in Review

Waters Parkerson & Co increased its Idexx Laboratories (IDXX) stake by 15% in Q2 2026, buying an estimated $84.1K and bringing the position to 1,160 shares worth $611K. The position accounts for 0.03% of the portfolio, ranked #130.

Waters Parkerson & Co first reported a position in IDXX in Q2 2020 and has held it in 25 quarters since. The position peaked at $683K in Q4 2025. 728 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Waters Parkerson & Co held 1,160 shares of Idexx Laboratories worth $611K as of Q2 2026.
  • Waters Parkerson & Co bought 150 Idexx Laboratories shares in Q2 2026, an estimated $84.1K.
  • Idexx Laboratories made up 0.03% of Waters Parkerson & Co's portfolio in Q2 2026, its #130 holding.
  • Waters Parkerson & Co first reported a position in Idexx Laboratories in Q2 2020 and has held it in 25 quarters since.
  • Waters Parkerson & Co's Idexx Laboratories position peaked at $683K in Q4 2025.
  • 728 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Waters Parkerson & Co's 13F filing for Q2 2026, filed 30 Jul 2026.